Artivion, Inc. (AORT)
USD 27.79
(-3.84%)
USD 27.79
(-3.84%)
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2023 | 229.17 Million USD | 5.66% |
| 2022 | 202.52 Million USD | 2.54% |
| 2021 | 197.51 Million USD | 17.72% |
| 2020 | 167.78 Million USD | -8.32% |
| 2019 | 183.01 Million USD | 5.8% |
| 2018 | 172.98 Million USD | 34.47% |
| 2017 | 128.64 Million USD | 8.19% |
| 2016 | 118.89 Million USD | 31.06% |
| 2015 | 90.71 Million USD | -0.63% |
| 2014 | 91.29 Million USD | 1.0% |
| 2013 | 90.38 Million USD | 6.31% |
| 2012 | 85.01 Million USD | 12.1% |
| 2011 | 75.84 Million USD | 10.93% |
| 2010 | 68.36 Million USD | -2.01% |
| 2009 | 69.76 Million USD | 2.91% |
| 2008 | 67.79 Million USD | 14.47% |
| 2007 | 59.22 Million USD | 34.93% |
| 2006 | 43.89 Million USD | 19.07% |
| 2005 | 36.86 Million USD | 48.88% |
| 2004 | 24.75 Million USD | -11.73% |
| 2003 | 28.05 Million USD | 130.64% |
| 2002 | 12.16 Million USD | -76.17% |
| 2001 | 51.04 Million USD | 8.67% |
| 2000 | 46.97 Million USD | 18.3% |
| 1999 | 39.7 Million USD | 2.07% |
| 1998 | 38.9 Million USD | 8.66% |
| 1997 | 35.8 Million USD | 38.76% |
| 1996 | 25.8 Million USD | 32.31% |
| 1995 | 19.5 Million USD | 25.0% |
| 1994 | 15.6 Million USD | 19.08% |
| 1993 | 13.1 Million USD | 21.3% |
| 1992 | 10.8 Million USD | 31.71% |
| 1991 | 8.2 Million USD | 0.0% |
| Year | Gross Profit | Gross Profit Growth |
|---|---|---|
| 2024 Q1 | 59.07 Million USD | -3.3% |
| 2024 Q2 | 59.36 Million USD | 0.49% |
| 2023 Q2 | 58.08 Million USD | 8.11% |
| 2023 Q4 | 61.09 Million USD | 8.57% |
| 2023 FY | 213.97 Million USD | 5.66% |
| 2023 Q1 | 53.72 Million USD | 5.58% |
| 2023 Q3 | 56.27 Million USD | -3.12% |
| 2022 FY | 202.52 Million USD | 2.54% |
| 2022 Q1 | 50.71 Million USD | -1.27% |
| 2022 Q2 | 52.17 Million USD | 2.86% |
| 2022 Q3 | 48.74 Million USD | -6.57% |
| 2022 Q4 | 50.88 Million USD | 4.4% |
| 2021 Q1 | 47.83 Million USD | 7.28% |
| 2021 Q2 | 50.51 Million USD | 5.59% |
| 2021 Q3 | 47.78 Million USD | -5.39% |
| 2021 Q4 | 51.37 Million USD | 7.5% |
| 2021 FY | 197.51 Million USD | 17.72% |
| 2020 FY | 167.78 Million USD | -8.32% |
| 2020 Q3 | 43.13 Million USD | 20.18% |
| 2020 Q1 | 44.17 Million USD | -5.11% |
| 2020 Q2 | 35.89 Million USD | -18.75% |
| 2020 Q4 | 44.59 Million USD | 3.38% |
| 2019 Q2 | 46.96 Million USD | 6.08% |
| 2019 FY | 183.01 Million USD | 5.8% |
| 2019 Q1 | 44.27 Million USD | -2.03% |
| 2019 Q3 | 45.22 Million USD | -3.71% |
| 2019 Q4 | 46.55 Million USD | 2.94% |
| 2018 Q2 | 45.85 Million USD | 16.88% |
| 2018 Q4 | 45.19 Million USD | 5.8% |
| 2018 Q3 | 42.71 Million USD | -6.84% |
| 2018 FY | 172.98 Million USD | 34.47% |
| 2018 Q1 | 39.22 Million USD | 7.88% |
| 2017 Q4 | 36.36 Million USD | 21.77% |
| 2017 Q3 | 29.86 Million USD | -9.25% |
| 2017 FY | 128.64 Million USD | 8.19% |
| 2017 Q2 | 32.9 Million USD | 11.5% |
| 2017 Q1 | 29.51 Million USD | -5.4% |
| 2016 Q2 | 30.3 Million USD | 9.7% |
| 2016 FY | 118.89 Million USD | 31.06% |
| 2016 Q1 | 27.62 Million USD | 4.17% |
| 2016 Q4 | 31.19 Million USD | 4.74% |
| 2016 Q3 | 29.78 Million USD | -1.71% |
| 2015 Q3 | 22.98 Million USD | 6.63% |
| 2015 Q2 | 21.55 Million USD | 9.59% |
| 2015 Q4 | 26.51 Million USD | 15.38% |
| 2015 FY | 90.71 Million USD | -0.63% |
| 2015 Q1 | 19.66 Million USD | -13.11% |
| 2014 Q4 | 22.63 Million USD | -4.89% |
| 2014 Q3 | 23.79 Million USD | 6.32% |
| 2014 Q1 | 22.47 Million USD | 0.86% |
| 2014 Q2 | 22.38 Million USD | -0.4% |
| 2014 FY | 91.29 Million USD | 1.0% |
| 2013 Q1 | 23.27 Million USD | 10.6% |
| 2013 Q2 | 21.47 Million USD | -7.72% |
| 2013 FY | 90.38 Million USD | 6.31% |
| 2013 Q4 | 22.28 Million USD | -4.57% |
| 2013 Q3 | 23.34 Million USD | 8.71% |
| 2012 Q4 | 21.04 Million USD | -1.24% |
| 2012 Q3 | 21.31 Million USD | -0.29% |
| 2012 Q2 | 21.37 Million USD | 0.37% |
| 2012 Q1 | 21.29 Million USD | 9.89% |
| 2012 FY | 85.01 Million USD | 12.1% |
| 2011 Q1 | 18.5 Million USD | 5.23% |
| 2011 Q4 | 19.37 Million USD | 2.45% |
| 2011 Q2 | 19.05 Million USD | 2.97% |
| 2011 Q3 | 18.91 Million USD | -0.74% |
| 2011 FY | 75.84 Million USD | 10.93% |
| 2010 Q4 | 17.58 Million USD | 15.52% |
| 2010 Q1 | 17.79 Million USD | 1.11% |
| 2010 Q2 | 17.76 Million USD | -0.13% |
| 2010 Q3 | 15.22 Million USD | -14.33% |
| 2010 FY | 68.36 Million USD | -2.01% |
| 2009 Q1 | 17.23 Million USD | 4.4% |
| 2009 Q3 | 17.04 Million USD | 95127.72% |
| 2009 FY | 69.76 Million USD | 2.91% |
| 2009 Q4 | 17.59 Million USD | 3.26% |
| 2009 Q2 | 17.89 Thousand USD | -99.9% |
| 2008 Q3 | 17.16 Million USD | -3.95% |
| 2008 Q1 | 16.25 Million USD | 0.64% |
| 2008 FY | 67.79 Million USD | 14.47% |
| 2008 Q2 | 17.86 Million USD | 9.89% |
| 2008 Q4 | 16.5 Million USD | -3.8% |
| 2007 FY | 59.22 Million USD | 34.93% |
| 2007 Q4 | 16.15 Million USD | 15.63% |
| 2007 Q3 | 13.97 Million USD | -1.3% |
| 2007 Q2 | 14.15 Million USD | -5.29% |
| 2007 Q1 | 14.94 Million USD | 49.43% |
| 2006 FY | 43.89 Million USD | 19.07% |
| 2006 Q4 | 10 Million USD | -12.94% |
| 2006 Q3 | 11.48 Million USD | -1.29% |
| 2006 Q2 | 11.63 Million USD | 8.13% |
| 2006 Q1 | 10.76 Million USD | 11.44% |
| 2005 FY | 36.86 Million USD | 48.88% |
| 2005 Q1 | 9.65 Million USD | 22.93% |
| 2005 Q3 | 8.5 Million USD | -6.03% |
| 2005 Q4 | 9.65 Million USD | 13.58% |
| 2005 Q2 | 9.04 Million USD | -6.23% |
| 2004 Q4 | 7.85 Million USD | 12.21% |
| 2004 Q2 | 5.87 Million USD | 45.61% |
| 2004 Q1 | 4.03 Million USD | 120.19% |
| 2004 FY | 24.75 Million USD | -11.73% |
| 2004 Q3 | 6.99 Million USD | 19.04% |
| 2003 FY | 28.05 Million USD | 130.64% |
| 2003 Q4 | 1.83 Million USD | -68.58% |
| 2003 Q3 | 5.83 Million USD | -31.74% |
| 2003 Q1 | 11.83 Million USD | 37.64% |
| 2003 Q2 | 8.54 Million USD | -27.79% |
| 2002 Q4 | 8.59 Million USD | 154.33% |
| 2002 Q3 | -15.82 Million USD | -475.25% |
| 2002 Q2 | 4.21 Million USD | -72.2% |
| 2002 Q1 | 15.17 Million USD | 17.12% |
| 2002 FY | 12.16 Million USD | -76.17% |
| 2001 Q1 | 12.32 Million USD | 5.77% |
| 2001 FY | 51.04 Million USD | 8.67% |
| 2001 Q4 | 12.95 Million USD | -1.73% |
| 2001 Q3 | 13.18 Million USD | 4.82% |
| 2001 Q2 | 12.57 Million USD | 2.03% |
| 2000 FY | 46.97 Million USD | 18.3% |
| 2000 Q4 | 11.65 Million USD | -3.79% |
| 2000 Q1 | 11.25 Million USD | 15.97% |
| 2000 Q2 | 11.94 Million USD | 6.16% |
| 2000 Q3 | 12.11 Million USD | 1.37% |
| 1999 Q2 | 10 Million USD | 4.17% |
| 1999 Q1 | 9.6 Million USD | 5.49% |
| 1999 Q4 | 9.7 Million USD | -6.67% |
| 1999 Q3 | 10.4 Million USD | 4.0% |
| 1999 FY | 39.7 Million USD | 2.07% |
| 1998 FY | 38.9 Million USD | 8.66% |
| 1998 Q1 | 10.1 Million USD | 6.32% |
| 1998 Q2 | 10.8 Million USD | 6.93% |
| 1998 Q3 | 9.7 Million USD | -10.19% |
| 1998 Q4 | 9.1 Million USD | -6.19% |
| 1997 Q1 | 7.5 Million USD | 25.0% |
| 1997 FY | 35.8 Million USD | 38.76% |
| 1997 Q3 | 9.5 Million USD | 3.26% |
| 1997 Q4 | 9.5 Million USD | 0.0% |
| 1997 Q2 | 9.2 Million USD | 22.67% |
| 1996 Q4 | 6 Million USD | -16.67% |
| 1996 Q3 | 7.2 Million USD | 7.46% |
| 1996 Q2 | 6.7 Million USD | 17.54% |
| 1996 Q1 | 5.7 Million USD | 16.33% |
| 1996 FY | 25.8 Million USD | 32.31% |
| 1995 Q2 | 4.8 Million USD | 9.09% |
| 1995 Q3 | 5.3 Million USD | 10.42% |
| 1995 Q4 | 4.9 Million USD | -7.55% |
| 1995 FY | 19.5 Million USD | 25.0% |
| 1995 Q1 | 4.4 Million USD | 10.0% |
| 1994 Q2 | 3.9 Million USD | 11.43% |
| 1994 Q4 | 4 Million USD | -2.44% |
| 1994 FY | 15.6 Million USD | 19.08% |
| 1994 Q1 | 3.5 Million USD | -2.78% |
| 1994 Q3 | 4.1 Million USD | 5.13% |
| 1993 Q2 | 3.2 Million USD | -31.91% |
| 1993 FY | 13.1 Million USD | 21.3% |
| 1993 Q1 | 4.7 Million USD | 2.17% |
| 1993 Q3 | 3.7 Million USD | 15.63% |
| 1993 Q4 | 3.6 Million USD | -2.7% |
| 1992 FY | 10.8 Million USD | 31.71% |
| 1992 Q1 | 4.5 Million USD | 4.65% |
| 1992 Q3 | 5.3 Million USD | 0.0% |
| 1992 Q2 | 5.3 Million USD | 17.78% |
| 1992 Q4 | 4.6 Million USD | -13.21% |
| 1991 Q1 | 2.9 Million USD | 0.0% |
| 1991 Q2 | 3.6 Million USD | 24.14% |
| 1991 Q3 | 4.5 Million USD | 25.0% |
| 1991 Q4 | 4.3 Million USD | -4.44% |
| 1991 FY | 8.2 Million USD | 0.0% |
| Name | Gross Profit | Gross Profit Difference |
|---|---|---|
| Abbott Laboratories | 22.13 Billion USD | 98.965% |
| Allurion Technologies Inc. | 41.49 Million USD | -452.271% |
| Avanos Medical, Inc. | 379.7 Million USD | 39.643% |
| Butterfly Network, Inc. | 16.85 Million USD | -1259.611% |
| Butterfly Network, Inc. | 16.85 Million USD | -1259.611% |
| Bio-Rad Laboratories, Inc. | 1.43 Billion USD | 83.989% |
| Boston Scientific Corporation | 9.89 Billion USD | 97.684% |
| Perspective Therapeutics, Inc. | 1.63 Million USD | -13925.459% |
| CONMED Corporation | 643.06 Million USD | 64.362% |
| Edwards Lifesciences Corporation | 4.62 Billion USD | 95.045% |
| Paragon 28, Inc. | 172.79 Million USD | -32.632% |
| Glaukos Corporation | 239.13 Million USD | 4.165% |
| Globus Medical, Inc. | 1.02 Billion USD | 77.538% |
| Inspire Medical Systems, Inc. | 528.22 Million USD | 56.614% |
| Integer Holdings Corporation | 418.28 Million USD | 45.211% |
| Medtronic plc | 19.45 Billion USD | 98.822% |
| Nevro Corp. | 290.06 Million USD | 20.99% |
| Owlet, Inc. | 22.58 Million USD | -914.637% |
| Penumbra, Inc. | 682.64 Million USD | 66.428% |
| Vicarious Surgical Inc. | -1.85 Million USD | 12461.165% |
| Smith & Nephew plc | 3.7 Billion USD | 93.808% |
| Sonendo, Inc. | 10.72 Million USD | -2037.437% |
| STERIS plc | 2.23 Billion USD | 89.741% |
| Stryker Corporation | 13.05 Billion USD | 98.245% |
| Vapotherm, Inc. | 28.28 Million USD | -710.296% |
| Zimmer Biomet Holdings, Inc. | 5.31 Billion USD | 95.684% |